Cuba: Second phase of trials with Soberana Plus in convalescent COVID-19 patients approved
The study, which will be developed at the Institute of Hematology and Immunology and at the National Center for Sex ...
The study, which will be developed at the Institute of Hematology and Immunology and at the National Center for Sex ...
After the start of the second stage of the process this Monday, more than 1,200 subjects in Havana received the ...
The provinces with the highest number of variants and patterns are Havana, Mayabeque and Pinar del Río.
“Should they prove successful, the (Cuban) vaccines would be an against-the-odds feat of medical prowess—as well as a public relations ...
The intervention study, approved by the Center for State Control of Medicines, Equipment and Medical Devices (CECMED), aims to evaluate ...
In a televised address, Venezuelan President Nicolás Maduro announced that 60,000 units will arrive in the country to be applied ...
The phase III trial for Abdala, from the Center for Genetic Engineering and Biotechnology (CIGB), will take place in the ...
At the end of Friday, the study was carried out in 40 vaccination centers, a figure that should increase in ...
The Cuban Biotechnology and Pharmaceutical Industries Business Group (BioCubaFarma) announced on Twitter the sending of the doses “as part of ...
The excellent results obtained so far with the Cuban vaccine candidate in phases I and II have allowed it to ...
Havana continues to report more daily cases, followed today by Camagüey, Mayabeque, Guantánamo, Pinar del Río and Santiago de Cuba, ...
The general director of the Finlay Vaccine Institute, Dr. Vicente Vérez, affirmed that this Cuban vaccine candidate has demonstrated a ...
A new molecular biology laboratory was inaugurated this February 21 in the province of Guantánamo, in eastern Cuba, for the ...
Specialists from the Cuban National Center for Seismological Research (CENAIS) are carefully observing the increase in seismic activity registered since ...
Researchers from the Center for Advanced Studies (CEA) of Cuba designed and produced a product for the diagnosis of PCR ...
Cuba is carrying out a clinical trial in people convalescing from COVID-19, who had a minor clinical picture or were ...
Cuba will produce this year 100 million doses of its Soberana 02 vaccine against the new coronavirus in order to ...
The Cuban Mambisa COVID-19 vaccine candidate concluded the period of clinical trials called “short cycle,” stipulated for days zero, 14 ...
A diagnostic kit for the detection of SARS-CoV-2 and new vaccine candidates more resistant to possible mutations of the coronavirus, ...
The clinical trial of the Cuban Abdala COVID-19 vaccine candidate in the eastern province of Santiago de Cuba―one of the ...
Cuba and Iran signed a bilateral agreement this Friday that establishes an alliance in the work for the development of ...
Damage to the lungs, followed by kidney and cardiovascular deterioration, are the main short-term sequelae that COVID-19 has produced on ...
The Cuban drug Itolizumab developed together with an Indian company, received authorization to begin a phase III clinical trial in ...
The Cuban Soberana 02 COVID-19 vaccine candidate will soon begin its clinical trials in humans, after its approval by the ...
Cuba began a new clinical trial aimed at curing the COVID-19 disease, produced by the SARS-CoV-2 virus, which to date ...
OnCuba and the OnCuba logo are registered® trademarks of Fuego Enterprises, Inc., its subsidiaries or divisions.
OnCuba © by Fuego Enterprises, Inc. All Rights Reserved.